Safety and Immunogenicity Study of tgAAC09, an HIV Vaccine in an Adeno-associated Virus (AAV) Capsid (TGC14F)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00888446
Recruitment Status : Completed
First Posted : April 27, 2009
Last Update Posted : December 17, 2012
Targeted Genetics Corporation
Information provided by (Responsible Party):
International AIDS Vaccine Initiative